Navigation Links
For insulin sensitive overweight patients, 1 session of exercise improves metabolic health
Date:9/24/2008

HILTON HEAD, SCOne out of every three Americans is obese. These individuals are at greater risk for additional diseases, since obesity leads to other health problems, such as diabetes.

Obesity-related complications are associated with an abnormal fat metabolism in the muscle. As a result, accumulated fat by-products inside the muscle affect insulin resistance. To avoid the build up of fat by-products, fat must either be oxidized (burned, as in exercise) or stored (as benign fat) in muscle.

A team of researchers has examined the effect of exercise on fat accumulation in a new study involving five obese women. In one session the women overate and did not exercise; in a follow-on session they overate and did exercise. The researchers found that:

  • the body's fat-burning oxidation rate was reduced after one day of overeating;

  • conversely, just one session of exercise increased the rate of fat-burning oxidation; and

  • exercise increased the amount of fat that would eventually be stored in the muscle.

The findings indicate that even one bout of exercise helps to reduce the fat by-products inside the muscle, which affects the insulin sensitivity. The findings also suggest that a single session of exercise "steers" muscle fat towards oxidation, thereby avoiding the accumulation of fat by-products.

The study was conducted by Andrea Cornford, Minghua Li, Simon Schenk, Matthew Harber and Jeffrey Horowitz, Division of Kinesiology, University of Michigan, Ann Arbor. Their research is entitled "Alteration in Lipid Metabolism After One Day of Overeating Are Reversed by a Single Session of Exercise." They will present their findings at a meeting sponsored by the American Physiological Society (APS; www.The-APS.org). The conference, The Integrative Biology of Exercise V, will be held September 24-27, 2008 in Hilton Head, SC. '/>"/>

Contact: Donna Krupa
DKrupa@the-aps.org
703-967-2751
American Physiological Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. Sugary drinks, not fruit juice, may be linked to insulin
2. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
3. Botched production of insulin molecule may lead to diabetes
4. Insulins brain impact links drugs and diabetes
5. Bypassing the insulin highway
6. A single mechanism for hypertension, insulin resistance and immune suppression
7. Trans-fatty acids and insulin sensitivity
8. Treatment corrects severe insulin imbalance in animal studies
9. UNC scientists turn human skin cells into insulin-producing cells
10. New chemically-sensitive MRI scan may bypass some invasive diagnostic tests in next decade
11. Researchers develop new ultrasensitive assay to detect most poisonous substance known

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ciated strain of the deadly superbug MRSAan infect...bioticsposes a far greater health threat than prev... according to a study in the December issue of Em...s easily picked up in fitness centers, schools, an...l burden of MRSA within hospitals, the report foun...
(Date:11/23/2009)...gests that a common oral bacterium may exacerbate ... et al, "Unique Lipids from a Common Human Bacteri...f Enhancing Autoimmunity," appears in the December.... , Multiple sclerosis (MS), a disease where the...affects nearly 1 in 700 people in the United State...
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 1VIASPACE Pursuing Renewable Energy Business in Asia 13353 2VIASPACE Pursuing Renewable Energy Business in Asia 13353 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 1Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 2Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 3Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 4Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 5Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 6Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 7Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 8Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 9Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 10Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 11Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 12Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 13Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 14Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 15Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 16Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 17Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 18Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 19Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 20Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 21Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 22Valeant Pharmaceuticals Reports Second Quarter Financial Results 53602 23
...veling the complex mechanisms in the brain that re...etites are controlled by systems very similar to t...type of neuron that is essential for feeding behav... and undergo rapid weight loss. , Remarkably, th...only influenced eating behavior when they were rem...
...des insight into genetic basis of human diseaseHig...lds a map of genetic variation which can give clue...he current technologies collect genotypes, or info...t many scientists believe that drilling down to th... of each chromosome -- so-called haplotypes -- wil...
...he last ice age are the likely culprits in the ext...rican great mammals such as mammoths, mastodons an...da researcher. , Determining whether the first arr...inent at the end of the last Ice Age was responsib...d scientists because both events occurred at the s...
Other Biology News:An essential regulator of body weight revealed 2An essential regulator of body weight revealed 3An essential regulator of body weight revealed 4California computer scientists double volume of data in NIH biotech repository 2California computer scientists double volume of data in NIH biotech repository 3California computer scientists double volume of data in NIH biotech repository 4Study shows big game hunters, not climate change, killed off sloths 2Study shows big game hunters, not climate change, killed off sloths 3
(Date:11/24/2009)... Health care employment grew ...he only one to show consistent growth during the U...itals remain in trouble, and health systems are co...onnel, instead of just administrators. , ...h care employment continued growing in October des...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuti...PTO)hasallowedthepatentapplicationfor,itsnano-part...ogyisahighlyefficientapproachtoincorporatepeptides...raldeliveryofdrugs,otherwiseadministeredasinjectio...liedtomanymacromoleculardrugssuchasinsulin,interfe...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolax...ion(SFDA)hasapprovedthe,investigationalnewdrugappl...novativeinsulinformulationtotreatdiabetes.ThisIND,...calstudy. , Diabetesisadisordercharacteristic...onsofdiabetesoftenresultinseveremicro-and,macro-va...
(Date:11/24/2009)... The FBI recently approved the ...ries participating in or generating DNA records fo... Madison, WI USA (PRWEB) -- The FBI recen...tem for use by laboratories participating in, or ... System (NDIS). NDIS currently contains more than ...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...ONDON, Aug. 27 Following the successful acquisiti...ry, Chiltern, a leading,contract research organiza... its two early Phase units into a single operation... Phase is providing high quality early phase servi...ll established units in Slough,(just outside of Lo...
...AN DIEGO and INDIANAPOLIS, Aug. 26 Amylin,Pharmac...Company (NYSE: LLY ),in a conference call today p...ng the August 18, 2008 U.S. Food and Drug Administ... (exenatide) injection referencing,pancreatitis. T...referenced,in the alert, as well as others, and pr...
...otes Secured by Royalties on U.S. Sales of SANCTUR...26 Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV )...ement to institutional investors of $105.0 million...e secured by royalties to be,paid from sales in th...,(trospium chloride). SANCTURA and SANCTURA XR are...
Other Biology Technology:Chiltern Early Phase: Fully Integrated and Business Ready 2Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 2Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 4Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 5Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 6Indevus Announces Private Placement of $105 Million of Non-Recourse Notes 2Indevus Announces Private Placement of $105 Million of Non-Recourse Notes 3Indevus Announces Private Placement of $105 Million of Non-Recourse Notes 4
Rabbit Anti-Schizosaccharomyces pombe SpUlp2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human STX18 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Human sRANKL Polyclonal Antibody, Biotin Conjugated from Cell Sciences
Mouse Anti-CD42d Monoclonal Antibody, Unconjugated, Clone CLB-SW16 (formerly 708) from Abcam
Biology Products: